Technical Analysis for ME - 23andMe Holding Co.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 3.15 | -8.16% | -0.28 |
ME closed down 8.16 percent on Wednesday, November 20, 2024, on 1.28 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: Nov 23
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 180 Bearish Setup | Bearish Swing Setup | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Slingshot Bearish | Bearish Swing Setup | -8.16% | |
| Bullish Engulfing | Bullish | -8.16% | |
| Pocket Pivot | Bullish Swing Setup | -8.16% | |
| Volume Surge | Other | -8.16% | |
| Lower Bollinger Band Walk | Weakness | -8.16% | |
| New 52 Week Low | Weakness | -8.16% |
| Alert | Time |
|---|---|
| Down 10% | about 16 hours ago |
| Down 5% | about 19 hours ago |
| Down 3% | about 20 hours ago |
| 60 Minute Opening Range Breakdown | about 21 hours ago |
| Down 2 % | about 21 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/23/2024
23andMe, Inc., a consumer genetics and research company, engages in developing a genetic database to unlock insights leading to the rapid discovery of new targets for drug development. It offers a crowdsourced platform that helps people to access, understand, and benefit from the human genome; access direct-to-consumer genetic testing; and give consumers personalized information about their genetic health risks, ancestry, and traits. The company was incorporated in 2006 and is based in Sunnyvale, California with an additional office in Mountain View, California.
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biology Genetics Genomics Drug Development Medical Genetics Applied Genetics Genetic Testing Human Genome
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biology Genetics Genomics Drug Development Medical Genetics Applied Genetics Genetic Testing Human Genome
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 20.4 |
| 52 Week Low | 2.655 |
| Average Volume | 321,569 |
| 200-Day Moving Average | 8.40 |
| 50-Day Moving Average | 5.45 |
| 20-Day Moving Average | 4.33 |
| 10-Day Moving Average | 3.90 |
| Average True Range | 0.46 |
| RSI (14) | 28.57 |
| ADX | 32.45 |
| +DI | 19.79 |
| -DI | 32.09 |
| Chandelier Exit (Long, 3 ATRs) | 3.96 |
| Chandelier Exit (Short, 3 ATRs) | 4.04 |
| Upper Bollinger Bands | 5.66 |
| Lower Bollinger Band | 3.00 |
| Percent B (%b) | 0.06 |
| BandWidth | 61.33 |
| MACD Line | -0.61 |
| MACD Signal Line | -0.50 |
| MACD Histogram | -0.1076 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.92 | ||||
| Resistance 3 (R3) | 3.97 | 3.78 | 3.79 | ||
| Resistance 2 (R2) | 3.78 | 3.58 | 3.75 | 3.74 | |
| Resistance 1 (R1) | 3.46 | 3.46 | 3.37 | 3.41 | 3.70 |
| Pivot Point | 3.27 | 3.27 | 3.22 | 3.24 | 3.27 |
| Support 1 (S1) | 2.95 | 3.07 | 2.86 | 2.90 | 2.60 |
| Support 2 (S2) | 2.76 | 2.95 | 2.73 | 2.56 | |
| Support 3 (S3) | 2.44 | 2.76 | 2.51 | ||
| Support 4 (S4) | 2.39 |
